Status:
UNKNOWN
The A-LIST WMM Insights Series
Lead Sponsor:
UsAgainstAlzheimer's
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
18-100 years
Brief Summary
The main purpose of the Study is to develop an understanding over time and through multiple research projects, including surveys, interviews, online focus groups, and other primary research methodolog...
Detailed Description
To do this, UsAgainstAlzheimer's will identify and engage individuals who want to focus on brain health; individuals who are worried about their cognition; individuals who perceive themselves to be at...
Eligibility Criteria
Inclusion
- To be eligible to participate in the Study, an individual must meet all of the following criteria:
- Age 18 years or older.
- United States, Canada resident.
- Self-report of cognitive difficulties, caregiver status or interest in brain health.
- Have indicated willingness to participate by selecting "I Agree" option when joining the A-LIST. Additionally, will have clicked on link - invitation to take a specific survey
- Able to speak, read, and understand English.
Exclusion
- An individual who meets any of the following criteria will be excluded from participation in this Study:
- 1\. Unable to comply with the Study requirements.
Key Trial Info
Start Date :
August 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04466722
Start Date
August 15 2018
End Date
December 31 2023
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UsAgainstAlzheimer's
Washington D.C., District of Columbia, United States, 20043